The global generic injectables market reached a value of US$ 33.82 Billion in 2020. Looking forward, the publisher expects the market to exhibit strong growth during 2021-2026. The report has segmented the market on the basis of therapeutic areas as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others.